Shortage of MTX | Arthritis Information

Share
 

Ok, I'm still looking for the one I actually read. But I found this article dated Mar 2005.  Even though it is in reference to childhood cancer, it explains the shortage a bit.  I've tried to type the first few words in all caps between the articles as a separator. 

http://www.rednova.com/news/display/?id=135933&source= r_health
Drug Shortage for Childhood Cancers

A U.S. shortage of injectable methotrexate -- a medication used in the treatment of several childhood cancers-- is alarming the nation's oncologists.

The drug was placed on the U.S. Food and Drug Administration's list of short supply drugs after a manufacturing plant in Switzerland was shut down last year because of quality-control problems, the Wall Street Journal reported Tuesday.

The plant supplied an estimated 85 percent of the drug used in the U.S. market. A third supplier has increased production of the drug, but hospitals are running low or are out of stock.

The drug is used for cancers, as well as rheumatoid arthritis, psoriasis, lupus and Crohn's disease. But the shortage mainly affects the nearly 4,500 U.S. children diagnosed annually with leukemia, osteosarcoma and non-Hodgkins lymphoma.

While adults with the same condition can take lower does in oral form, children need extremely high doses that they can get only in the injectable form.

AHhhh ha.  I found a more recent one!!! Still not the one I saw but... oh well.  I'm not sure what the RTOG Study 0227 is or what it is even for.  Most likely cancer.
http://www.rtog.org/members/protocols/0227/0227broadcast.h tml
UBJECT: RTOG STUDY 0227: Shortage of preservative-free methotrexate

At this time (and possibly for the next several months) there is an extreme shortage of preservative-free methotrexate; most of the major wholesalers in the US and Canada have none in stock.

There are two manufacturers with a very limited stock that is being released on an as-need basis. Investigators who enroll patients into RTOG Study 0227 should remind their pharmacists of the shortage and suggest they call the manufacturers' customer service department to discuss purchasing a supply of methotrexate directly or via drop-shipment instead of trying to order MTX through their local wholesalers.

The manufacturers are:
Mayne Pharmaceuticals: 1-888-606-2245
Bedford Labs: 1-800-521-5169

AND FINALLY from the FDA-
http://www.fda.gov/cder/drug/shortages/#Current

Methotrexate injection with preservative  25mg/mL/2mL vials

updated 4/25/2005
 

American Pharmaceutical Partners (APP)
Customer Service #1-888-386-1300.
Manufacturing delays

 
FDA and APP are working together to address this shortage Mayne Pharma
customer service #
1-866-594-8420

  Manufacturing delays Mayne has stopped allocating this product and is filling orders under normal distribution. The product will temporarily be distributed with a Canadian label (with both English and French text). Physicians and pharmacists may contact the company for additional information.

 
Bedford
customer service # 1-800-562-4797
Limited supply of preservative free  FDA and Bedford are working together to meet the supply and demand Methotrexate injection 1 gram vials

updated 4/14/2005
Mayne Pharma customer service # 1-866-594-8420 Manufacturing delays
  Mayne Pharma has received approval to additionally provide vials of methotrexate injection solution which will temporarily have Canadian labeling (English and French).  Physicians and pharmacists may contact the company for further information.

Methotrexate 1 gram vials are not yet available from APP.

 

American Pharmaceutical Partners (APP) Customer Service #1-888-386-1300.


 Thanks ,now I know more about the shortage then my doc and the pharmacy. Guess I'll just be on the pills for awhile. once again thank you so much.       Rita
Copyright ArthritisInsight.com